Kidney Allograft Fibrosis: Diagnostic and Therapeutic Strategies

Area of Science:

• Nephrology
• Immunology
• Pathology

Background:

• Interstitial fibrosis with tubule atrophy (IF/TA) is a common response to kidney injury, impacting kidney function and allograft survival.
• Multiple pathways, including hypoxia and inflammation, contribute to IF/TA progression.

Purpose of the Study:

• To review key pathways in renal fibrosis development.
• To discuss diagnostic and therapeutic strategies for allograft fibrosis.
• To highlight the role of myofibroblasts in renal fibrosis.

Main Methods:

• Literature review focusing on renal fibrosis pathways, myofibroblast biology, and therapeutic targets.
• Summary of multiomic approaches for biomarker discovery.
• Review of current imaging strategies and clinical trials for IF/TA.

Main Results:

• IF/TA is driven by diverse pathways and myofibroblasts are central matrix-producing cells.
• Multiomic approaches show promise for IF/TA detection and survival prediction.
• Imaging strategies and ongoing clinical trials offer new avenues for managing kidney fibrosis.

Conclusions:

• Understanding IF/TA pathways and myofibroblast biology is crucial for developing effective treatments.
• Novel biomarkers and non-invasive imaging techniques are needed for early IF/TA detection and monitoring.
• Targeted therapies and ongoing clinical trials hold promise for improving outcomes in kidney fibrosis.